WHO ICTRP trial
A Bioequivalence study of a randomized, open-label, single dose, two-way…
TCTR20230130001 · Thai Clinical Trials Registry (TCTR) · Not Recruiting
Key facts
| Trial ID | TCTR20230130001 |
|---|---|
| Public title | A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Sitagliptin 100 mg (Film-coated Tablet) relative to Originator Januvia 100 mg in healthy Thai volunteers under fasting condition |
| Scientific title | A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Generic Sitagliptin 100 mg (Film-coated Tablet) relative to Originator JanuviaTM 100 mg (Sitagliptin 100 mg-Filmcoated Tablet) in healthy Thai volunteers under… |
| Primary sponsor | Bio-innova Co., Ltd. |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Thailand |
| Conditions | Healthy subjects Bioequivalence Sitagliptin 100 mg (Film-coated Tablet) ;Bioequivalence Sitagliptin 100 mg (Film-coated Tablet) |
| Interventions | The new generic products which were recently developed. Volunteer will receive a single dose of Sitagliptin 100 mg Film-coated Tablet either test or reference with 250mL of drinking water,The marketed original products which were already… |
| Registration date | Jan 30, 2023 |
| Target size | 26 |
| Secondary IDs | Nil Known |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: